Cargando…
Iron Deposits in Periaqueductal Gray Matter Are Associated with Poor Response to OnabotulinumtoxinA in Chronic Migraine
Previous studies have reported increased brain deposits of iron in patients with chronic migraine (CM). This study aims to determine the relation between iron deposits and outcome after treatment with OnabotulinumtoxinA (OnabotA). Demographic and clinical data were collected for this study through a...
Autores principales: | Domínguez Vivero, Clara, Leira, Yago, Saavedra Piñeiro, Marta, Rodríguez-Osorio, Xiana, Ramos-Cabrer, Pedro, Villalba Martín, Carmen, Sobrino, Tomás, Campos, Francisco, Castillo, José, Leira, Rogelio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472356/ https://www.ncbi.nlm.nih.gov/pubmed/32731573 http://dx.doi.org/10.3390/toxins12080479 |
Ejemplares similares
-
Pentraxin 3 (PTX3): A Molecular Marker of Endothelial Dysfunction in Chronic Migraine
por: Domínguez-Vivero, Clara, et al.
Publicado: (2020) -
Mild systemic inflammation enhances response to OnabotulinumtoxinA in chronic migraineurs
por: Leira, Yago, et al.
Publicado: (2021) -
Cognitive effects of onabotulinumtoxinA in chronic migraine
por: Ho, Susan, et al.
Publicado: (2020) -
OnabotulinumtoxinA: Still the Present for Chronic Migraine
por: Baraldi, Carlo, et al.
Publicado: (2023) -
Triptan efficacy does not predict onabotulinumtoxinA efficacy but improves with onabotulinumtoxinA response in chronic migraine patients
por: Eren, Ozan E., et al.
Publicado: (2020)